loadpatents
Patent applications and USPTO patent grants for Ullrich; John W..The latest application filed is for "isolated hydroxy and n-oxide metabolites and derivatives of o-desmethylvenlafaxine and methods of treatment".
Patent | Date |
---|---|
Indoline derivatives Grant 7,645,761 - Fensome , et al. January 12, 2 | 2010-01-12 |
Indazoles Grant 7,592,363 - Steffan , et al. September 22, 2 | 2009-09-22 |
Quinolines and pharmaceutical compositions thereof Grant 7,576,215 - Collini , et al. August 18, 2 | 2009-08-18 |
Isolated hydroxy and n-oxide metabolites and derivatives of O-desmethylvenlafaxine and methods of treatment App 20080261895 - Hoffmann; Matthew J. ;   et al. | 2008-10-23 |
Indoline derivatives App 20070259944 - Fensome; Andrew ;   et al. | 2007-11-08 |
Ethers of O-desmethyl venlafaxine Grant 7,291,646 - Yardley , et al. November 6, 2 | 2007-11-06 |
Indoline derivatives Grant 7,253,203 - Fensome , et al. August 7, 2 | 2007-08-07 |
Indoline derivatives Grant 7,084,168 - Fensome , et al. August 1, 2 | 2006-08-01 |
Indoline derivatives App 20060160882 - Fensome; Andrew ;   et al. | 2006-07-20 |
Substituted 2-phenyl benzofurans as estrogenic agents App 20060074128 - Miller; Christopher P. ;   et al. | 2006-04-06 |
Substituted 2-phenyl benzofurans as estrogenic agents Grant 7,022,733 - Miller , et al. April 4, 2 | 2006-04-04 |
Indazoles useful in treating cardiovascular diseases App 20060030612 - Steffan; Robert J. ;   et al. | 2006-02-09 |
Quinolines useful in treating cardiovascular disease App 20050131014 - Collini, Michael D. ;   et al. | 2005-06-16 |
Substituted 2-phenyl benzofurans as estrogenic agents App 20050038107 - Miller, Christopher P. ;   et al. | 2005-02-17 |
3,3-substituted indoline derivatives Grant 6,835,744 - Ullrich , et al. December 28, 2 | 2004-12-28 |
Substituted 2-phenyl benzofurans as estrogenic agents Grant 6,774,248 - Miller , et al. August 10, 2 | 2004-08-10 |
Ethers of o-desmethyl venlafaxine App 20040147601 - Yardley, John P. ;   et al. | 2004-07-29 |
Indoline derivatives App 20030220388 - Fensome, Andrew ;   et al. | 2003-11-27 |
Substituted 2-phenyl benzofurans as estrogenic agents App 20030171428 - Miller, Christopher P. ;   et al. | 2003-09-11 |
Ethers of O-Desmethyl venlafaxine App 20030158253 - Yardley, John P. ;   et al. | 2003-08-21 |
Indoline derivatives Grant 6,608,068 - Fensome , et al. August 19, 2 | 2003-08-19 |
Cyclic regimens utilizing indoline derivatives Grant 6,544,970 - Grubb , et al. April 8, 2 | 2003-04-08 |
Cyclic regimens utilizing indoline derivatives App 20030050288 - Grubb, Gary S. ;   et al. | 2003-03-13 |
3,3-substituted indoline derivatives App 20030008909 - Ullrich, John W. ;   et al. | 2003-01-09 |
Cyclic regimens utilizing indoline derivatives Grant 6,462,032 - Grubb , et al. October 8, 2 | 2002-10-08 |
3,3-substituted indoline derivatives Grant 6,417,214 - Ullrich , et al. July 9, 2 | 2002-07-09 |
Indoline derivatives App 20020086874 - Fensome, Andrew ;   et al. | 2002-07-04 |
Indoline derivatives Grant 6,391,907 - Fensome , et al. May 21, 2 | 2002-05-21 |
Ethers of O-Desmethyl venlafaxine App 20020037922 - Yardley, John P. ;   et al. | 2002-03-28 |
Combination regimens using 3,3-substituted indoline derivatives App 20020035099 - Grubb, Gary S. ;   et al. | 2002-03-21 |
Combination regimens using 3,3-substituted indoline derivatives Grant 6,329,416 - Grubb , et al. December 11, 2 | 2001-12-11 |
Cycloalkyl amine bis-aryl squalene synthase inhibitors Grant 5,451,596 - Ullrich , et al. September 19, 1 | 1995-09-19 |
Azacyclic bisphosphonates as anticholesterolemic agents Grant 5,317,015 - Ullrich , et al. May 31, 1 | 1994-05-31 |
Novel HMG-COA reductase inhibitors Grant 4,992,429 - Ullrich , et al. February 12, 1 | 1991-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.